Volume 26, Number 6—June 2020
Dispatch
Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016
Kaitlin Benedict
, George R. Thompson, and Brendan R. Jackson
, George R. Thompson, and Brendan R. Jackson
Table
Characteristics of patients with fungal infections, by cannabis use status, United States, 2016*
| Characteristic |
Persons who use cannabis, n = 40 |
Persons who do not use cannabis, n = 6,294 |
p value |
| Median age, y (range) | 41.5 (7–70) | 56 (0–99) | <0.001 |
| 0–17 | 1 (3) | 341 (5) | |
| 18–34 | 16 (40) | 659 (10) | |
| 35–44 | 4 (10) | 745 (12) | |
| 45–54 | 5 (13) | 1,226 (19) | |
| 55–64 | 13 (33) | 1,816 (29) | |
| >65 |
1 (3) |
1,507 (24) |
|
| Sex | |||
| M | 25 (63) | 3,078 (49) | 0.086 |
| F |
15 (37) |
3,216 (51) |
|
| US Census Region† | 0.964 | ||
| Northeast | 5 (13) | 689 (11) | |
| Midwest | 10 (25) | 1,581 (25) | |
| South | 12 (30) | 2,099 (33) | |
| West |
13 (33) |
1,915 (30) |
|
| Immunocompromised | 17 (43) | 1,303 (21) | <0.001 |
| Inpatient on fungal infection diagnosis date |
16 (40) |
820 (13) |
<0.001 |
| Type of fungal infection | |||
| Aspergillosis | 17 (43) | 2,091 (33) | |
| Blastomycosis | 1 (3) | 218 (3) | |
| Coccidioidomycosis | 10 (25) | 1,661 (26) | |
| Cryptococcosis | 4 (10) | 338 (5) | |
| Histoplasmosis | 7 (18) | 1,945 (31) | |
| Mucormycosis |
1 (3) |
82 (1) |
|
| Tobacco use | 16 (40) | 558 (9) | <0.001 |
*Values are no. (%) unless otherwise indicated.
†Of primary beneficiary’s residence.
Page created: May 19, 2020
Page updated: May 19, 2020
Page reviewed: May 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.